Martin I. Andrews
Mechelen-bovelingen, VLG 2800, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
HBsAg Suppression by a New Series of HBV RNA Destabilizers: Discovery and Effects on In Vitro Neurite Outgrowth.
Journal: Journal of medicinal chemistry
Published: January 20, 2026
Discovery and Characterization of GLPG3808, a PAPD5/7 Inhibitor for Suppression of Hepatitis B Viral Infections.
Journal: Journal of medicinal chemistry
Published: January 20, 2026
Targeted Delivery of Oligonucleotide-Peptide Conjugates for Enhanced Kidney-Specific Therapy.
Journal: Journal of medicinal chemistry
Published: September 17, 2025
Discovery of Clinical Candidate GLPG3970: A Potent and Selective Dual SIK2/SIK3 Inhibitor for the Treatment of Autoimmune and Inflammatory Diseases.
Journal: Journal of medicinal chemistry
Published: March 29, 2024
Optimization of Selectivity and Pharmacokinetic Properties of Salt-Inducible Kinase Inhibitors that Led to the Discovery of Pan-SIK Inhibitor GLPG3312.
Journal: Journal of medicinal chemistry
Published: December 26, 2023
Correction to "Discovery of GLPG2451, a Novel Once Daily Potentiator for the Treatment of Cystic Fibrosis".
Journal: Journal of medicinal chemistry
Published: September 14, 2021
Discovery of GLPG2451, a Novel Once Daily Potentiator for the Treatment of Cystic Fibrosis.
Journal: Journal of medicinal chemistry
Published: January 05, 2021
Identification and Characterization of Novel CFTR Potentiators.
Journal: Frontiers in pharmacology
Published: July 26, 2018
PI4KIII inhibitor enviroxime impedes the replication of the hepatitis C virus by inhibiting PI3 kinases.
Journal: The Journal of antimicrobial chemotherapy
Published: March 05, 2018
Discovery of N-(3-Carbamoyl-5,5,7,7-tetramethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-2-yl)-lH-pyrazole-5-carboxamide (GLPG1837), a Novel Potentiator Which Can Open Class III Mutant Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channels to a High Extent.
Journal: Journal of medicinal chemistry
Published: November 18, 2017
Identification of a series of compounds with potent antiviral activity for the treatment of enterovirus infections.
Journal: ACS medicinal chemistry letters
Published: March 08, 2013
Discovery of a series of imidazopyrazine small molecule inhibitors of the kinase MAPKAPK5, that show activity using in vitro and in vivo models of rheumatoid arthritis.
Journal: Bioorganic & medicinal chemistry letters
Published: December 20, 2011
Last Updated: 09/26/2026